Could not attend? BioLife Solutions’ Posters Presented During ISCT 2019 International Meeting in Melbourne

Posters presenting data for T-cells cryopreserved in CryoStor® cryopreservation solution, authored by BioLife Solutions’ Alireza Abazari, Ph.D., Scientific Applications Director and Aby J. Mathew, Ph.D., Senior Vice President & Chief Technology Officer, were featured during the International Society for Cell & Gene Therapy meeting in Melbourne, Australia, May 29 – June 1, 2019. View the…

Read More

TrakCel and Quick Partnering Solution

According to data provided by the Alliance for Regenerative Medicine, there are nearly 900 companies responsible for more than 1000 industry-sponsored clinical trials within regenerative medicine utilizing advanced therapeutics including cell, gene, and tissue engineered products. Maintaining oversight on these precious therapies, literally vein-to-vein, encompassing a multitude of stakeholders, lengthy timelines, across countries and continents…

Read More

BioPreservation Blog 1/30/2019

Disease models facilitate understanding the pathogenesis of disease, identification and development of potential interventions and evaluation of new treatments. BioLife Solutions maintains an online, searchable, Evidence Library that contains over 365 articles, abstracts and posters citing Biopreservation efficacy of CryoStor® and HypoThermosol®. Recently added to the Evidence Library, the journal article authored by Xinyue Bai…

Read More

BioPreservation Blog 12/20/18

One of the benefits of cryopreserving cells is the flexibility in scheduling for later use that freezing provides. Determining the optimal solution for cryopreservation that consistently results in post-thaw recovery of the greatest number of highly viable, functional cells is crucial. The article by Sara S. Parker et al. published in eNeuro and recently added…

Read More

BioPreservation Blog 8/8/2018

The number of applications for BioLife Solutions’ biopreservation reagents continues to grow, and we are pleased to highlight these newest citations: Habiel, D., Espindola, M., Coelho, A., & Hogaboam, C. Modeling Idiopathic Pulmonary Fibrosis in Humanized SCID Mice. The American Journal of Pathology 2018 Apr; 188(4): 891-903. doi: 10.1016/j.ajpath.2017.12.020 Habiel et. al. provided detailed methods for the creation…

Read More

Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine Conjugated Antibody–Drug Conjugate Targeting 5T4

Harper, Lloyd, Dimasi, Toader, Marwood, Lewis, Bannister, Jovanovic, Fleming, d’Hooge, Mao, Marrero, Korade, Strout, Xu, Chen, Wetzel, Breen, van Vlerken-Ysla, Jalla, Rebelatto, Zhong, Hurt, Hinrichs, Huang, Howard, Tice, Hollingsworth, Herbst, Kamal. Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine Conjugated Antibody–Drug Conjugate Targeting 5T4. Mol Cancer Ther; 16(8) August 2017. DOI: 10.1158/1535-7163.MCT-16-0825

Read More